Abstract
Sexual dysfunction is a common side effect of most antidepressants. Lower rates are reported with some newer agents such as reboxetine and bupropion. The evidence base for its management is limited but growing, with most approaches only tested in a small number of trials. Available strategies include watchful waiting, the use of short drug holidays, and a change of antidepressant. Many specific antidotes have been trialed but with lack of convincing benefit in most cases. However, where antidepressants cause erectile dysfunction, the use of sildenafisl has the largest and most consistent evidence base.
Similar content being viewed by others
References and Recommended Reading
Rudkin L, Taylor MJ, Hawton K: Strategies for managing sexual dysfunction induced by antidepressant medication. Cochrane Database Syst Rev 2004, 4:CD003382. Periodically updated systematic review of RCTs of strategies for managing antidepressant-induced sexual dysfunction.
Angst J: Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol 1998, 13(Suppl 6):S1-S4.
Montgomery SA, Baldwin DS, Riley A: Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction. J Affect Disord 2002, 69:119–140.
Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F: Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry 2001, 62(Suppl 3):10–21.
Clayton AH, Pradko JF, Croft HA, et al.: Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 2002, 63:357–366.
Williams VS, Baldwin DS, Hogue SL, et al.: Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a crosssectional patient survey. J Clin Psychiatry 2006, 67:204 -210.
Croft H, Settle E, Jr, Houser T, et al.: A placebo-controlled comparison of the antidepressant Efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Clin Ther 1999, 21:643–658.
Coleman CC, Cunningham LA, Foster VJ, et al.: Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment. Ann Clin Psychiatry 1999, 11:205–215.
Coleman CC, King BR, Bolden-Watson C, et al.: A placebocontrolled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine. Clin Ther 2001, 23:1040–1058.
Clayton AH, Croft HA, Horrigan JP, et al.: Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. J Clin Psychiatry 2006, 67:736–746.
Kennedy SH, Fulton KA, Bagby RM, et al.: Sexual function during bupropion or paroxetine treatment of major depressive disorder. Can J Psychiatry 2006, 51:234–242.
Clayton AH, Zajecka J, Ferguson JM, et al.: Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder. Int Clin Psychopharmacol 2003, 18:151–156.
Baldwin D, Bridgman K, Buis C: Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine. J Psychopharmacol 2006, 20:91–96.
Langworth S, Bodlund O, Agren H: Efficacy and tolerability of reboxetine compared with citalopram: a double-blind study in patients with major depressive disorder. J Clin Psychopharmacol 2006, 26:121–127.
Delgado PL, Brannan SK, Mallinckrodt CH, et al.: Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder. J Clin Psychiatry 2005, 66:686–692.
Ferguson JM, Shrivastava RK, Stahl SM, et al.: Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline. J Clin Psychiatry 2001, 62:24–29.
Nurnberg HG, Gelenberg A, Hargreave TB, et al.: Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. Am J Psychiatry 2001, 158:1926–1928.
Ginsberg DL, Adler L, McCullough A, et al.: Sildenafil treatment of serotonin-reuptake inhibitor (SRI)-induced sexual dysfunction. Paper presented at 41st Annual New Clinical Drug Evaluation Unit (NCDEU) Meeting. Phoenix, AZ; May 28–31, 2001.
Nurnberg HG, Hensley PL, Gelenberg AJ, et al.: Treatment of antidepressant-associated sexual dysfunction with sildenafil. JAMA 2003, 289:56–64.
Fava M, Nurnberg HG, Seidman SN, et al.: Efficacy and safety of sildenafil in men with serotonergic antidepressantassociated erectile dysfunction: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2006, 67:240–246. Largest single randomized trial indicating benefit of sildenafil in antidepressant-induced erectile dysfunction.
Segraves RT, Stevenson RW, Lee J, et al.: Tadalafil treatment of erectile dysfunction in men on antidepressants. Paper presented at 157th Annual Meeting of the American Psychiatric Association. New York; May 1–6, 2004.
Clayton AH, Warnock JK, Kornstein SG, et al.: A placebocontrolled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 2004, 65:62–67.
Masand PS, Ashton AK, Gupta S, Frank B: Sustainedrelease bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study. Am J Psychiatry 2001, 158:805–807.
Debattista C, Solvason B, Poirier J, et al.: A placebocontrolled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRIinduced sexual dysfunction. J Clin Psychiatry 2005, 66:844–848.
Landen M, Eriksson E, Agren H, Fahlen T: Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 1999, 19:268–271.
Michelson D, Bancroft J, Targum S, et al.: Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention. Am J Psychiatry 2000, 157:239–243.
Kang BJ, Lee SJ, Kim MD, Cho MJ: A placebo-controlled, double-blind trial of Ginkgo biloba for antidepressantinduced sexual dysfunction. Hum Psychopharmacol 2002, 17:279–284.
Wheatley D: Triple-blind, placebo-controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugs. Hum Psychopharmacol 2004, 19:545–548.
Jespersen S, Berk M, Van Wyk C, et al.: A pilot randomized, double-blind, placebo-controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use. Int Clin Psychopharmacol 2004, 19:161–164.
Nelson EB, Shah VN, Welge JA, Keck PE: A placebo-controlled, crossover trial of granisetron in SRI-induced sexual dysfunction. J Clin Psychiatry 2001, 62:469–473.
Michelson D, Kociban K, Tamura R, Morrison MF: Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake-associated female sexual dysfunction: a randomized, placebo controlled trial. J Psychiatr Res 2002, 36:147–152.
Ernst E, Pittler MH: Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol 1998, 159:433–436.
Meston CM: A randomized, placebo-controlled, crossover study of ephedrine for SSRI-induced female sexual dysfunction. J Sex Marital Ther 2004, 30:57–68.
Rothschild AJ: Selective serotonin reuptake inhibitorinduced sexual dysfunction: Efficacy of a drug holiday. Am J Psychiatry 1995, 152:1514–1516.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Taylor, M.J. Strategies for managing antidepressant-induced sexual dysfunction: A review. Curr Psychiatry Rep 8, 431–436 (2006). https://doi.org/10.1007/s11920-006-0047-6
Issue Date:
DOI: https://doi.org/10.1007/s11920-006-0047-6